NOVT
Novanta Inc.
NOVT's fundamentals are mixed: revenue grew 13%, but its operating margin fell 2 points to 7.8%. At 89x earnings, it's trading in line with its usual 86x.
NOVT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Strong | |
| Weak |
NOVT's revenue and cash flow are currently healthy, and its profitability is stable, but its balance sheet is weak.
NOVT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 72x | $94.82 | -19% |
| Fair | 86x | $113 | -3.6% |
| Current | 89x | $117 | — |
| Expensive | 106x | $140 | +19% |
Historical ranges are pointers, not guarantees.
NOVT's PE is in its fair range at 89x.
NOVT Forward outlook
There aren't enough analyst estimates for NOVT to show an outlook.
NOVT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $1.32 | -9.6% |
| Q2 2026 | $1.57 | -7.1% |
| Q1 2026 | $1.39 | -29% |
| Q4 2025 | $1.47 | -17% |
| Q3 2025 | $1.46 | -12% |
| Q2 2025 | $1.69 | -1.7% |
| Q1 2025 | $1.95 | +1.6% |
| Q4 2024 | $1.77 | -12% |
NOVT's earnings per share have fallen from their peak: $1.32 over the past year, against $2.13 in mid-2023.
NOVT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $305M | +23% |
| Q2 2026 | $265.8M | +10% |
| Q1 2026 | $257.7M | +10% |
| Q4 2025 | $258.3M | +8.5% |
| Q3 2025 | $247.8M | +1.4% |
| Q2 2025 | $241M | +2.2% |
| Q1 2025 | $233.4M | +1.1% |
| Q4 2024 | $238.1M | +13% |
NOVT's revenue has grown year over year for 11 quarters in a row: $305M last quarter, up 23% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 4.6% | -4.3 points |
| Q2 2026 | 6.8% | +0.6 points |
| Q1 2026 | 11% | -3.2 points |
| Q4 2025 | 9.6% | -1.6 points |
| Q3 2025 | 8.8% | -4.5 points |
| Q2 2025 | 6.2% | -4.7 points |
| Q1 2025 | 14% | +2.8 points |
| Q4 2024 | 11% | +1 points |
NOVT's operating margin was 4.6% last quarter, down 4.3 points from the same quarter a year ago, near the bottom of its range since 2019.
NOVT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $30.4M | +621% |
| Q2 2026 | $57.5M | +392% |
| Q1 2026 | $47.5M | +73% |
| Q4 2025 | $5.1M | -91% |
| Q3 2025 | $4.2M | -78% |
| Q2 2025 | $11.7M | -68% |
| Q1 2025 | $27.4M | +3.7% |
| Q4 2024 | $59.3M | +81% |
NOVT's free cash flow has been positive every quarter for seven years: $140M over the past year, up 37% from the year before.
NOVT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.8% | +1.5M shares |
| 1 year | +19% | +6.7M shares |
| 3 years | +19% | +6.7M shares |
| 5 years | +19% | +6.9M shares |
| Available history | +20% | +7.2M shares |
NOVT has 43M diluted shares, up 19% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $18.6M |
| Q4 2025 | $19.1M |
| Q3 2025 | $14.1M |
| Q2 2025 | — |
| Q1 2025 | $6.2M |
| Q4 2022 | — |
NOVT spent $38M buying back its own shares over the past year.
NOVT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 4.3x | High |
| Q2 2026 | -3.2x | Net Cash |
| Q1 2026 | -1.0x | Net Cash |
| Q4 2025 | -0.8x | Net Cash |
| Q3 2025 | 2.3x | Moderate |
| Q2 2025 | 2.1x | Moderate |
| Q1 2025 | 1.6x | Healthy |
| Q4 2024 | 1.8x | Healthy |
NOVT's net debt is about 4.3 years of its operating earnings (EBITDA), up from 2.3 years a year ago.
NOVT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 39.5 | Neutral |
| Stochastic | 18.1 | Oversold |
NOVT's weekly RSI is 39 (neutral) and its Stochastic is 18 (oversold).
NOVT PE vs Technology Sector
| Metric | NOVT | Sector median | Relative |
|---|---|---|---|
| PE | 89x | 28x | 219% above |
| PE % | 55 | 35 | 20 pts above |
NOVT is trading at 89x earnings, a 219% premium to the Technology sector's median of 28x.
NOVT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $137.8 | 15% below |
| 20 week MA | $145.1 | 19% below |
| 50 week MA | $138.9 | 15% below |
| 100 week MA | $132.3 | 11% below |
| 200 week MA | $147.5 | 20% below |
NOVT is in a downtrend: it's below all five of its weekly moving averages, and 20% below its 200-week average.
NOVT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $89.8 | $120.8 | +34% |
| 2021 | $120.8 | $173.1 | +43% |
| 2022 | $173.1 | $137.9 | -20% |
| 2023 | $137.9 | $168.4 | +22% |
| 2024 | $168.4 | $154.7 | -8.1% |
| 2025 | $154.7 | $122.7 | -21% |
| 2026 YTD | $122.7 | $117.4 | -4.3% |
NOVT has finished lower in three of the last six years. It's down 4.3% so far in 2026.